Clinical Trials Sponsored by Joyce Fox

Total 18049 results

Medy-Tox

Completed

Efficacy and Safety of MEDITOXIN® in Cervical Dystonia (CD Phase III)

Cervical Dystonia
Medy-Tox

Completed

Efficacy and Safety Study of MT10109L in the Treatment of Glabella Line(Including a Preliminary Study to Evaluate Safety of MT10109L)

Glabella Line Severity

Korea, Republic of
Medy-Tox

Completed

Medytoxin® Treatment in Patients With Benign Masseteric Hypertrophy

Hypertrophy of Masseter Muscle

Korea, Republic of
Medy-Tox

Completed

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Hyperhidrosis | Anhidrotic Area

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety of Potenfill for Temporary Penile Enhancement

Penile Enhancement

Korea, Republic of
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

Glabellar Lines
Medy-Tox

Completed

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Essential Blepharospasm
Medy-Tox

Completed

Efficacy and Safety Evaluation Study of Neuramis® Deep Lidocaine in Correction of Nasolabial Fold

Nasolabial Fold

Korea, Republic of
Medy-Tox

Completed

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Cervical Dystonia

Australia
Medy-Tox

Completed

MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Russian Federation, Germany, Canada, Belgium, United Kingdom
Medy-Tox

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Glabellar Frown Lines

Australia
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines

Lateral Canthal Lines

United States, Russian Federation, United Kingdom
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines

Glabellar Lines

United States, Belgium, Russian Federation
Medy-Tox

Completed

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada
Medy-Tox

Completed

MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)

Lateral Canthal Lines | Glabellar Lines

United States, Germany, Canada, United Kingdom
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase1)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

CORETOX® in Treatment of Post Stroke Upper Limb Spasticity (Phase3)

Muscle Spasticity

Korea, Republic of
Medy-Tox

Completed

Neuramis® Volume Lidocaine for Volume Augmentation in the Mid-Face

Mid Face Volume Loss

China
Medy-Tox

Completed

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Medy-Tox

Completed

Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®

Healthy Volunteers

Korea, Republic of
Medy-Tox

Completed

The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Russian Federation
Medy-Tox

Completed

MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy

Masseter Muscle Hypertrophy

Korea, Republic of
Medy-Tox

Completed

Neuramis® Deep Lidocaine Compared to YVOIRE® Volume Plus for Correction of Nasolabial Folds

Nasolabial Folds

China
Medy-Tox

Completed

Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

Hyperhidrosis Primary Focal Axilla

Korea, Republic of
Medy-Tox

Completed

MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity

Spasticity

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines

Skin Aging

Korea, Republic of
Medy-Tox

Completed

Treatment of MEDITOXIN® in Female Patients With Idiopathic Overactive Bladder

Overactive Bladder

Korea, Republic of
Medy-Tox

Completed

Meditoxin® Treatment in Patients With Cervical Dystonia

Dystonia | Dystonic Disorder

Korea, Republic of
Medy-Tox

Completed

Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers

Healthy

Korea, Republic of
Medy-Tox

Completed

Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm

Essential Blepharospasm

Korea, Republic of
Sunnybrook Health Sciences Centre
Terry Fox Research Institute

Not yet recruiting

Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Locally Advanced Breast Cancer-Phase II

Breast Cancer

Canada
Fox Chase Cancer Center
National Cancer Institute (NCI)

Recruiting

PHL Treatment in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

United States
Fox Chase Cancer Center
Celgene Corporation; Seagen Inc.

Active, not recruiting

A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL)

United States
Fox Chase Cancer Center
University of Wisconsin, Madison

Active, not recruiting

A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Carcinoma Breast Stage IV

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer

Stage IA Non-small Cell Lung Cancer | Stage IB Non-small Cell Lung Cancer | Stage IIA Non-small Cell Lung Cancer | Stage IIB Non-small Cell Lung Cancer

United States
Fox Chase Cancer Center
Eli Lilly and Company

Terminated

Pemetrexed and Gemcitabine in Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations

Breast Cancer | BRCA1 Mutation

United States, Austria
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Stage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural Effusion | Malignant Pericardial Effusion

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery

Acinar Cell Adenocarcinoma of the Pancreas | Duct Cell Adenocarcinoma of the Pancreas | Stage III Pancreatic Cancer | Stage IIB Pancreatic Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Unknown

Molecular Analysis in Tissue Samples From Patients With Advanced or Metastatic Neuroendocrine Tumors

Neuroendocrine Tumor

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Terminated

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Mucinous Adenocarcinoma of the Rectum | Signet Ring Adenocarcinoma of the Rectum | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Mucinous Adenocarcinoma of the Colon | Signet Ring Adenocarcinoma of the Colon | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage... and other conditions

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Pancreatic Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Neurotoxicity | Peripheral Neuropathy | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Long-Term Effect of Adolescent Diet on Hormones and Breast Cancer Risk in Women Previously Enrolled in the Dietary Intervention Study in Children

Breast Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia

Cervical Cancer | Precancerous Condition

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer

Prostate Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Colorectal Cancer | Hereditary Non-polyposis Colon Cancer

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Withdrawn

Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Lung Cancer

United States

Clinical Trials Sponsored by Joyce Fox

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations